Radiation Oncology/Therapy: Page 112

Sequential and alternating chemoradiotherapy comparable for laryngeal cancer
By Reuters Health
NEW YORK (Reuters Health), Feb 6 - The results of a randomized trial indicate that sequential and alternating chemotherapy with radiotherapy provide similar survival and larynx preservation in patients with advanced squamous cell cancer of the larynx.
February 5, 2009
Reuterslogo
Varian brings RapidArc to Belgium
By AuntMinnieEurope.com staff writers
Radiation therapy firm Varian Medical Systems has installed its RapidArc radiotherapy technology at its first hospital in Belgium.
February 1, 2009
Elekta awarded Russian contracts
By AuntMinnieEurope.com staff writers
Swedish oncology firm Elekta has received orders from Russia for its Axesse whole-body robotic image-guided stereotactic treatment management system.
January 29, 2009
Elekta wins contracts in Sweden, Estonia
By AuntMinnieEurope.com staff writers
Swedish oncology firm Elekta has received contracts to install its radiotherapy systems at three hospitals in Sweden and Estonia, the Stockholm-based company announced.
January 26, 2009
Varian builds user base
By AuntMinnieEurope.com staff writers
Radiation therapy firm Varian Medical Systems said that Südharz-Krankenhaus in Nordhausen, Germany, has become the first German user of its RapidArc radiotherapy treatment.
January 26, 2009
Eckert & Ziegler acquires Nuclitec
By AuntMinnieEurope.com staff writers
Radiotherapy and radiopharmaceutical developer Eckert & Ziegler Strahlen-und Medizintechnik has acquired Nuclitec and its two French and U.S. affiliates.
January 25, 2009
EU health chief says cancer screenings must double
By Reuters Health
BRUSSELS (Reuters), Jan 23 - Europe needs to conduct twice as many cancer screenings to prevent death rates from the disease from climbing as the population ages, the European Union (EU) health commissioner said on Thursday.
January 22, 2009
Reuterslogo
Isodose Control rolls out Flexiplan 2.5
By AuntMinnieEurope.com staff writers
Isodose Control of Ede, Netherlands, has released its new Flexiplan 2.5 brachytherapy planning system.
January 18, 2009
Internal mammary node biopsies needed for better RT planning
By Cynthia E. Keen
A large study of breast cancer patients reveals that only 5% of patients with cancer-positive internal mammary nodes who receive radiation therapy (RT) will die of breast cancer recurrence within five years. This survival rate is comparable to patients with positive axillary lymph nodes who receive radiation therapy.
December 30, 2008
Screening for thyroid cancer worthwhile in some childhood cancer survivors
By Reuters Health
NEW YORK (Reuters Health), Dec 29 - While ultrasound screening for thyroid cancer in the general population is not cost-effective and may lead to unnecessary surgery, it is worthwhile in childhood cancer survivors who received radiotherapy involving the head, neck, or upper thorax, according to Italian researchers.
December 28, 2008
Reuterslogo
IBA gets FDA nod for pencil-beam scanning
By AuntMinnieEurope.com staff writers
Radiopharmaceutical firm Ion Beam Applications (IBA) has received clearance from the U.S. Food and Drug Administration for its pencil-beam scanning treatment option for proton therapy.
December 18, 2008
Chemoradiotherapy feasible for elderly patients with esophageal cancer
By Reuters Health
NEW YORK (Reuters Health), Dec 18 - Definitive chemoradiotherapy is an effective treatment that can be dispensed with no significant toxicity in elderly patients with locally advanced esophageal cancer, according to a 13-year study conducted at Rouen University Hospital in France.
December 17, 2008
Reuterslogo
Previous Page
Page 112 of 127
Next Page